Document Detail


Synergistic effects of photodynamic therapy with HPPH and gemcitabine in pancreatic cancer cell lines.
MedLine Citation:
PMID:  23018618     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND AND OBJECTIVE: Photodynamic therapy (PDT) is a potential treatment for pancreatic cancer. A second-generation photosensitizer, 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide (HPPH) has a long wavelength absorption, high-tumor selectivity, and shorter duration of skin photosensitivity. We investigated the efficacy of PDT with HPPH and gemcitabine in inducing cell death in multiple pancreatic cancer cell lines.
METHODS: We used three pancreatic cancer cell lines (PANC-1, MIA PaCa-2, and BXPC-3) incubated with HPPH concentration of 0, 0.005, 0.01, 0.025, 0.05, 0.1, 0.25, and 0.5 µg/ml for 6 hours, followed by photoradiation at a light dose of 60 J/cm(2). Afterwards, each cell line was treated with gemcitabine at concentrations of 0, 1, 10, and 100 µM and incubated for another 96 hours. Cell death was detected with SYTOX green staining. We also assessed the difference in cytotoxicity in adding gemcitabine before and after PDT.
RESULTS: HPPH-PDT can effectively induce cell death in all cell lines in a dose-dependent manner, with a 100% of cell death at the 0.5 µg/ml HPPH concentration. In contrast, monotherapy with gemcitabine alone (100 µM) only achieved <45% cell death. Combining gemcitabine to HPPH-PDT resulted in synergistic cytotoxic effect with 20-50% more cell death across all cell lines. There was no difference in cytotoxicity in adding gemcitabine before or after PDT.
CONCLUSION: This is the first study on HPPH-PDT for pancreatic cancer. HPPH-PDT-induced cell death occurs in a dose-dependent manner. HPPH-PDT and gemcitabine have synergistic effects in inducing cell death in multiple pancreatic cancer cell lines.
Authors:
Gang Sun; Marlys A Anderson; Emmanuel C Gorospe; Cadman L Leggett; Lori S Lutzke; Louis M Wong Kee Song; Michael Levy; Kenneth K Wang
Related Documents :
24414058 - Leaf structure in relation to solute transport and phloem loading in zea mays l.
24429388 - Cell penetration to nanofibrous scaffolds: forcespinning®, an alternative approach for...
22761038 - The molecular circuitry underlying pluripotency in embryonic stem cells.
24204978 - Critical role of a ferritin-like protein in the control of listeria monocytogenes cell ...
22014028 - Sensory epithelial cells acquire features of prosensory cells via epithelial to mesench...
17112618 - Uptake and metabolism of novel biodegradable poly (glycerol-adipate) nanoparticles in d...
Publication Detail:
Type:  Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't     Date:  2012-09-27
Journal Detail:
Title:  Lasers in surgery and medicine     Volume:  44     ISSN:  1096-9101     ISO Abbreviation:  Lasers Surg Med     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-10-30     Completed Date:  2013-04-22     Revised Date:  2013-06-03    
Medline Journal Info:
Nlm Unique ID:  8007168     Medline TA:  Lasers Surg Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  755-61     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 Wiley Periodicals, Inc.
Affiliation:
Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antimetabolites, Antineoplastic / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / pharmacology,  therapeutic use*
Cell Death / drug effects
Cell Line, Tumor
Chlorophyll / administration & dosage,  analogs & derivatives
Deoxycytidine / administration & dosage,  analogs & derivatives
Dose-Response Relationship, Drug
Drug Synergism
Humans
Pancreatic Neoplasms / drug therapy*
Photochemotherapy*
Photosensitizing Agents / administration & dosage
Chemical
Reg. No./Substance:
0/Antimetabolites, Antineoplastic; 0/Photosensitizing Agents; 1406-65-1/Chlorophyll; 149402-51-7/2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a; 951-77-9/Deoxycytidine; B76N6SBZ8R/gemcitabine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  StAR-related lipid transfer domain protein 5 binds primary bile acids.
Next Document:  Rapid fabrication of nanostructured surfaces using nanocoining.